AUA 2018: Augmenix, Inc. Announces Exciting Plans for the 2018 American Urological Association Meeting in San Francisco

Truckee, CA ( -- Augmenix, Inc. is pleased to announce that they will be exhibiting at this year’s American Urological Association meeting in San Francisco, California. Located at Booth 6251 Hall D, the company will be featuring their leading product, SpaceOAR® hydrogel, which is used in patients receiving radiation therapy for prostate cancer. Attendees of the AUA meeting are invited to visit the exhibit to learn about the latest developments that make SpaceOAR hydrogel the #1 rectal spacer for prostate cancer radiotherapy worldwide.

Highlights Include:

In booth presentations from Urology experts including Dr. Katsuto Shinohara, from the University of California, San Francisco who will speak about the clinical benefits and procedural overview of SpaceOAR hydrogel. Dr. Evan Goldfischer from the Premier Medical Group and Clinical Assistant Professor of Urology at the New York Medical College will speak about integrating SpaceOAR hydrogel into office-based Urology practices. Mark Painter, CEO of PRS, LLC will present the recent positive developments in national reimbursement for the SpaceOAR hydrogel procedure.

Augmenix will also unveil its new customized hands-on simulators at the exhibit, designed to provide Urologists with the ability to perform the SpaceOAR procedure before using it with patients.

The company will also formally launch the Augmenix Spacing Academy, designed to provide the information, tools and on-site support to enable Urologists to experience consistent and optimal patient outcomes.

Further Related Content:

Watch: SpaceOAR® Hydrogel Application Video -Marcio Fagundes
Absorbable Hydrogel Spacer Use in Prostate Radiotherapy: Review of Phase 3 Clinical Trial Published Data: Beyond the Abstract by Neal Shore
email news signup